PLK1 gene suppresses cell invasion of undifferentiated thyroid carcinoma through the inhibition of CD44v6, MMP-2 and MMP-9. This evidence concerns the gene PLK1 and thyroid gland undifferentiated (anaplastic) carcinoma.